Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation

v3.24.1.u1
Share-based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation

NOTE 10 – SHARE-BASED COMPENSATION

Global Stock Incentive Plan

On May 31, 2023, the shareholders of the Company approved the Company’s Board of Directors proposal to increase the Company’s 2020 Global Incentive Plan (the “Plan”) by an additional 500,000 shares, thus bringing the total number of stock options, restricted stock units (“RSUs”) and restricted stock awards (“RSAs”) that may be issued pursuant to the Plan to 2,450,855.

 

Under the term of the Plan, on the grant date, the Board of Directors determines the vesting schedule of each stock option and RSUs on an individual basis. All stock options expire ten (10) years from the date of the grant. Vested options expire 90 days after the termination of employment of the grantee.

Stock Options

There were no options granted for the three months ended March 31, 2024. The fair value of options granted under the Plan during the three months ended March 31, 2023 was estimated at the date of grant using the Black-Scholes option pricing model and the following assumptions for grants:

 

 

2023

 

Risk-free interest rates

 

 

3.43

%

Expected life

 

5 years

 

Expected volatility

 

 

41.00

%

Expected dividend yield

 

 

0.00

%

 

The following table summarizes the stock option activity:

 

(in thousands except share and per share data)

 

 

 

 

 

 

 

Weighted Average

 

 

Aggregate

 

 

Number of

 

 

Weighted Average

 

 

Remaining

 

 

Intrinsic

 

 

Options

 

 

Exercise Price

 

 

Contractual Term

 

 

Value

 

Balance at January 1, 2024

 

 

1,213,957

 

 

$

4.43

 

 

 

8.70

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited/Cancelled

 

 

(78,325

)

 

 

7.11

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2024

 

 

1,135,632

 

 

 

4.22

 

 

 

5.49

 

 

$

187

 

Exercisable at March 31, 2024

 

 

704,005

 

 

$

4.98

 

 

 

5.23

 

 

$

52

 

 

The following table summarizes the Company’s non-vested stock options:

 

 

 

 

 

Weighted-Average

 

 

Non-vested Options

 

 

Grant Date Fair

 

 

Outstanding

 

 

Value

 

At January 1, 2024

 

 

506,522

 

 

$

1.67

 

Options granted

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(7,830

)

 

 

2.75

 

Options exercised

 

 

 

 

 

 

Options vested

 

 

(67,065

)

 

 

1.70

 

At March 31, 2024

 

 

431,627

 

 

$

1.65

 

 

For the three months ended March 31, 2024 and 2023, the Company recognized $121 thousand and $216 thousand of stock compensation expense relating to stock options, respectively. As of March 31, 2024, there was $696 thousand of unrecognized stock compensation expense related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of approximately 2.5 years.

 

Restricted Stock Awards

In July 2019, the Board of Directors of the Company authorized grants of RSAs through a restricted stock award purchase agreement to certain founders, consultants, and advisors of the Company. Certain grants to the Company’s founders were fully vested at the date of incorporation, other grants vest over a four-year period on each anniversary of the grant date, based on continued employment, and other grants vest based on various milestones. The shares of common stock underlying the RSAs were issued upon grant.

For the three months ended March 31, 2024 and 2023, the Company recognized $0 and $121 thousand of stock compensation expense relating to RSAs, respectively. As of March 31, 2024, there was $0 of unrecognized compensation expense related to unvested restricted share awards.

Restricted Stock Units

The following table summarizes the restricted stock units activity:

 

 

 

Outstanding

 

 

Value

 

Outstanding at January 1, 2024

 

 

 

 

$

 

Granted

 

 

350,000

 

 

 

1.78

 

Forfeited/cancelled

 

 

 

 

 

 

Vested

 

 

(115,000

)

 

 

1.73

 

Outstanding at March 31, 2024

 

 

235,000

 

 

$

1.81

 

 

For the three months ended March 31, 2024 and 2023, the Company recognized $440 thousand and $286 thousand of stock compensation expense relating to RSUs, respectively. As of March 31, 2024, there was $2.6 million of unrecognized compensation expense remaining related to unvested restricted share units.